Hutchinson's Melanotic Freckle
"Hutchinson's Melanotic Freckle" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a "starburst" appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma.
| Descriptor ID |
D018327
|
| MeSH Number(s) |
C04.557.465.625.650.510.385 C04.557.580.625.650.510.385 C04.557.665.510.385
|
| Concept/Terms |
Hutchinson's Melanotic Freckle- Hutchinson's Melanotic Freckle
- Freckle, Hutchinson's Melanotic
- Hutchinson Melanotic Freckle
- Hutchinsons Melanotic Freckle
- Melanotic Freckle, Hutchinson's
- Melanotic Freckle
- Lentigo, Malignant
- Lentigos, Malignant
- Malignant Lentigo
- Malignant Lentigos
- Freckle, Melanotic
- Freckles, Melanotic
- Melanotic Freckles
- Lentigo Maligna
|
Below are MeSH descriptors whose meaning is more general than "Hutchinson's Melanotic Freckle".
Below are MeSH descriptors whose meaning is more specific than "Hutchinson's Melanotic Freckle".
This graph shows the total number of publications written about "Hutchinson's Melanotic Freckle" by people in this website by year, and whether "Hutchinson's Melanotic Freckle" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hutchinson's Melanotic Freckle" by people in Profiles.
-
Kunishige JH, Brodland DG, Zitelli JA. Reply to: "Five-millimeter lateral margins are appropriate in the treatment of melanoma in situ". J Am Acad Dermatol. 2020 05; 82(5):e165.
-
Kunishige JH, Doan L, Brodland DG, Zitelli JA. 9-mm Surgical margin required for both LM and MIS as diagnosed in real-world community practice. J Am Acad Dermatol. 2019 10; 81(4):e117-e118.
-
Kunishige JH, Doan L, Brodland DG, Zitelli JA. Comparison of surgical margins for lentigo maligna versus melanoma in situ. J Am Acad Dermatol. 2019 Jul; 81(1):204-212.
-
Stigall LE, Brodland DG, Zitelli JA. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities. J Am Acad Dermatol. 2016 Nov; 75(5):1015-1021.
-
Valent?n SM, Brodland DG, Zitelli JA. Optimal treatment for lentigo maligna. Plast Reconstr Surg. 2012 Dec; 130(6):888e-889e.
-
Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ. J Am Acad Dermatol. 2012 Mar; 66(3):438-44.
-
Hendi A, Brodland D, Zitelli JA. Melanocytic hyperplasia in sun-exposed skin has been defined. Dermatol Surg. 2011 Apr; 37(4):550.
-
Demirci H, Shields CL, Bianciotto CG, Shields JA. Topical imiquimod for periocular lentigo maligna. Ophthalmology. 2010 Dec; 117(12):2424-9.
-
Murchison AP, Washington CV, Soloman AR, Bernardino CR. Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatol Surg. 2007 Sep; 33(9):1136-8.
-
Zitelli JA. Surgical margins for lentigo maligna, 2004. Arch Dermatol. 2004 May; 140(5):607-8.